Jitendra Wadhane
Prin Fin & Acct Officer · Pyxis Oncology, Inc.
Individual
- 2024
- Mar 25, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jitendra Wadhane files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jakob Dupont - $107K in PYXS purchases and sales in the last 12 months
- GordonMD Global Investments LP - PYXS
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jitendra Wadhane?
Jitendra Wadhane is a corporate insider, tracked as Prin Fin & Acct Officer of Pyxis Oncology, Inc. (PYXS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jitendra Wadhane last file a Form 4?
The most recent primary Form 4 on record is dated 25 March 2026, one of 2 filings going back to 2024.
